Asia-Pacific Respiratory Device Market Trends 2019 | Segmentation, Outlook, Industry Report to 2025
Asia-Pacific Respiratory Device
Market is estimated to grow $10.5 billion in 2027
from $6.9 billion in 2020, growing at a CAGR of 6.1% during the forecast period
(2021-2027). Asia-Pacific region is considered to be the most emerging market
due to the significant growth of the healthcare system in Asia-Pacific
countries, such as India, China, and South Korea. Asia-Pacific region is
forecast to witness immense growth due to significant investment by government
and major market players, favorable government policies, and a high patient
base. Asia-Pacific region covers more than 60% of the global population, has a
high prevalence of respiratory diseases, such as asthma and COPD. These factors
are expected to drive the growth of the market in the near future. Increasing
air pollution in India is also one of the major causes of the growth of the
respiratory device market.
To Request
a Sample of our Report on Asia-Pacific Respiratory Device Market: https://www.omrglobal.com/request-sample/asia-pacific-respiratory-device-market
Growing
Demand for Respiratory Device Market
The Asia-Pacific respiratory devices market presents future
opportunities for growth as the prevalence of respiratory diseases such as
asthma and COPD in emerging economies such as India and China. In addition, the
increasing geriatric population specially in Japan is another major reason for
the growing market.
(Get 15% Discount on Buying this Report)
A
full Report of Asia-Pacific Respiratory Device Market is Available
at: https://www.omrglobal.com/industry-reports/asia-pacific-respiratory-device-market
Scope
of the Asia-Pacific Respiratory Device Market
Market
Coverage
- The market
number available - 2020-2027
- Base year-
2020
- Forecast
period- 2021-2027
·
Segment Covered- By Product, By End-User
·
Regions Covered- Asia-Pacific (India, China, Japan,
and Rest of Asia-Pacific)
·
Competitive Landscape- Cipla Ltd., Novartis AG, Mylan N.V.,
Koninklijke Philips N.V., BMC Medical Co., Ltd.
Recent Strategic Initiatives in
the Asia-Pacific Respiratory Device Market
·
In May 2018, the company acquired NightBalance for expanding its
sleep & respiratory care portfolio. The acquisition enables Philips
Healthcare to expand its position in the home care market. In May 2017, Philips
acquired the US-based RespirTech which provides solutions for chronic
respiratory conditions such as pulmonary disease and cystic fibrosis. The
acquisition enables the company to expand respiratory care, especially COPD
patients with bronchiectasis.
·
In January 2018, Resmed
introduced Mobi which is a portable oxygen concentrator (POC). In May 2017,
Resmed launched AirTouch F20 full face mask with UltraSoft memory for
comfortable therapy of the patients. In
January 2017 the company got FDA approval for AirMini. It is one of the
smallest CPAP machines. In November 2016 Company launched AirFit N20 and AirFit
F20 CPAP Masks.
Asia-Pacific
Respiratory Device Market -Segmentation
By Product
- Respiratory
Therapeutic Devices
- Respiratory
Positive Airway Pressure Devices
- Respiratory Mask
- Respiratory
Ventilators
- Respiratory
Oxygen Concentrators
- Respiratory
Inhalers
- Respiratory
Resuscitators
- Respiratory
Nebulizers
- Respiratory
Humidifiers
- Respiratory
Nitric Oxide Delivery Units
- Respiratory
Oxygen Hoods
- Respiratory
Diagnostic and Monitoring Devices
- Respiratory
Pulse Oximeters
- Respiratory Capnography
- Respiratory Gas
Analyzers
- Respiratory
Spirometers
- Respiratory
Polysomnography (PSG) Devices
- Respiratory Peak
Flow Meters
- Respiratory
Consumables and Accessories
- Respiratory
Tracheostomy Tubes
- Respiratory
Nasal Cannulas
- Respiratory
Disposable Mask
- Respiratory
Disposable Resuscitators
- Respiratory
Other Consumables and Accessories
By
End-User
- Hospitals
- Home Care
- Other End-Users
Asia-Pacific
Respiratory Device Market – Segment by Region
Asia-Pacific
India
·
China
·
Japan
·
Rest of Asia-Pacific
Company
Profiles
·
3M Co.
·
Acorda Therapeutics, Inc.
·
Adamis Pharmaceuticals Corp.
·
Adherium Ltd.
·
Aradigm Corp.
·
AstraZeneca PLC
·
Beximo Pharmaceuticals Ltd.
·
BMC Medical Co., Ltd.
·
Boehringer Ingelheim
International GmbH
·
Cipla Ltd.
·
GlaxoSmithKline PLC
·
Koninklijke Philips N.V.
·
MidasCare Pharmaceutical Pvt.
Ltd.
·
Mylan N.V.
·
Novartis AG
·
Omron Healthcare Inc.
·
ResMed Corp.
·
Sunovion Pharmaceuticals
·
Teijin Pharma Ltd.
·
Teva Pharmaceuticals Industries
Ltd.
Reasons to Buying From us –
1.
We cover more than 15 major industries, further segmented into more than
90 sectors.
2.
More than 120 countries are for analysis.
3.
Over 100+ paid data sources mined for investigation.
4.
Our expert research analysts answer all your questions before and after
purchasing your report.
For More
Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/asia-pacific-respiratory-device-market
About Orion
Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other research-based
services.
For
More Information, Visit Orion Market Research
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment